Abiopharma

Puma Biotechnology, Inc. - Puma Biotechnology to Present at the H.C. Wainwright 27th Annual Global Investment Conference

New Form SCHEDULE 13G/A - Praxis Precision Medicines, Inc. Filed: 2025-09-02 AccNo: 0000902664-25-003938 Size: 12 KB

Puma Biotechnology to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Lifecore Biomedical to Participate in Upcoming Investor Conferences

Lyell Immunopharma Announces Participation in September Investor Conferences

STRATA Skin Sciences to Present at the H.C.Wainwright 27th Annual Global Investment Conference

New Form 144 - Health Catalyst, Inc. Filed: 2025-09-02 AccNo: 0001636422-25-000128 Size: 4 KB

Indaptus Therapeutics Notification (INDP)

New Form 144 - DEXCOM INC Filed: 2025-09-02 AccNo: 0001950047-25-006589 Size: 5 KB

New Form 8-K - MSP Recovery, Inc. Filed: 2025-09-02 AccNo: 0001802450-25-000066 Size: 261 KB Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01: Financial Statements and Exhibits

Aligos Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Sight Sciences Announces Recognition of theTearCare® System in TFOS DEWS III Global Dry Eye Guidelines Published in AJO

New Form 144 - Teladoc Health, Inc. Filed: 2025-09-02 AccNo: 0001959173-25-005703 Size: 5 KB

Akebia Therapeutics Reports Inducement GrantsUnder Nasdaq Listing Rule 5635(c)(4)

Quince Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference